. They remain ubiquitous environmental contaminants found in high concentrations in both human and animal tissues (3) despite their production being banned in the United States in the 1970s. Two types of observations about PCBs are central to the current study. First, PCBs are developmental neurotoxins. Schantz et al. (4) reviewed this literature for humans and concluded that, on balance, there is strong evidence indicating that PCB exposure is associated with negative effects on cognitive development. Interestingly, many different neuropsychological strategies have been used to identify effects of PCB exposure on cognitive function, providing additional strength for this conclusion.
These correlative studies in humans are consistent with controlled experiments in animals. Developmental exposure to PCBs can affect hearing (5, 6) , motor activity in an open field test, and operant behavior (7, 8) . In addition, PCBs can affect neurite outgrowth in culture (9) . Thus, PCBs are developmental neurotoxins in both humans and experimental animals.
A second type of observation documents human exposures and body burdens. In general, these exposures to PCBs are high enough to be associated with adverse effects on brain development in humans as described above, and they provide a context for animal exposure studies. For example, a recent study by Lackmann et al. (10) found that 6-wk-old breast-fed infants had serum PCB levels of 1.19 g/liter, which was significantly higher than the 0.29 g/liter found in the serum of bottle-fed infants. Furthermore, Kalantzi et al. (11) reported that total PCB levels in breast milk in the United Kingdom ranged from 26 to 530 ng/g lipid, translating to a daily infant intake of 6.24 -2067 ng/kg⅐d. In addition, She et al. (12) recently reported PCB levels in milk samples collected from women in the Pacific Northwest of the United States. On average, these milk samples had PCB levels of 147 ng/g lipid, which translates to an approximate daily intake of 1 g/kg⅐d. Considering that the halflife of PCB congeners in the human body ranges from years to decades (e.g. Ref. 13 ), PCBs clearly accumulate, accounting for PCB levels in brain tissues of adult humans at autopsy in the micromolar range (14, 15) . Thus, PCBs remain important contaminants in human tissues and are associated with adverse effects on brain development.
Some investigators speculate that one mechanism by which PCBs may produce neurotoxic affects is by interfering with normal thyroid hormone (TH) action during development (16, 17) . Early findings showed that accidental exposure to PCBs reduced serum TH levels in humans (18) ; these findings are supported in more recent studies (19) . Findings in animal studies almost uniformly show that PCBs reduce serum TH (20 -22) . Moreover, Crofton (5) reported a correlation between the PCB-induced reduction in serum T 4 during development and hearing loss in rats. Therefore, it is possible that PCBs can exert adverse effects on the developing brain by causing a reduction in serum thyroid hormones.
Although PCBs reduce circulating TH levels in animals, they do not produce effects on the developing brain that are fully consistent with the effects of low T 4 . For example, developmental PCB exposure increases the expression of several known TH-responsive genes, including HES1 in the fetal rat brain, Malic enzyme in the maternal rat liver, and RC3/ neurogranin in the neonatal cerebral cortex and hippocampus (23) (24) (25) , despite causing a severe reduction in serum total and free T 4 . Furthermore, PCB exposure does not recapitulate the effect of hypothyroidism on the cellular composition of white matter in rat pups, despite causing a reduction in circulating T 4 (26) . Thus, PCBs may exert agonistic effects on TH signaling, perhaps by acting directly on the TH receptor (TR). This concept is supported by the observation that specific PCB congeners can produce TH-like effects on oligodendrocyte differentiation in vitro (27) and on GH3 cell proliferation and GH secretion (28) . In addition, individual PCB metabolites can bind to the human TR (29) and can activate the rat TR using a reporter assay (30) .
However, other studies report that PCBs can antagonize the TR. Specific PCB congeners inhibit T 3 -mediated dendritic growth in cerebellar Purkinje cells in vitro (31) . In addition, PCBs can inhibit T 3 -induced gene activation in transient transfection assays (32) (33) (34) . Taken together, these findings indicate that the actions of PCBs on TH signaling are complex but that they could account, at least in part, for their neurotoxic effects.
To discriminate between PCB effects on TH signaling in the developing brain by their ability to reduce circulating TH or by their ability to interact directly with the TR, we performed a two-factor experiment in which the effects of PCB treatment was tested on TH signaling in euthyroid animals and hypothyroid animals. We reasoned that if PCBs can exert a direct action on TH signaling in the developing brain, then this effect should be observable in animals deprived of TH. We used a PCB formulation, Aroclor 1254 (A1254), known to reduce serum TH levels and produce thyroid hormone-like effects (25) . These TH-like effects appear to be mediated by specific metabolites of PCB congeners enriched in A1254 (36) . We evaluated two kinds of TH-dependent end points as a way of monitoring TH signaling in the developing brain. First, we evaluated the effect of PCBs on the expression of two genes known to be direct targets of TH, including RC3/ neurogranin in the hippocampus (25, 37) and Purkinje cell protein (PCP)-2 in the cerebellum (38) . RC3 appears to be regulated by the ␣-isoform of TR, whereas PCP-2 appears to be regulated by the ␤-isoform (39) . Second, we evaluated the effect of PCBs on cerebellar histogenesis. The cerebellum is particularly sensitive to TH insufficiency during development (40) , exhibiting a delay in granule cell proliferation in and migration from the external granule layer (EGL) (41) . The effect of TH on cerebellar granule cell migration appears to be mediated by the ␣-isoform of TR (42) .
Materials and Methods

Experimental animals
All animal procedures were performed according to the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996) and were approved by the University of Massachusetts-Amherst Institutional Animal Care and Use Committee. Timed pregnant Sprague Dawley rats (n ϭ 32; Zivic Miller Inc., Pittsburgh, PA) arrived at our facility on gestational day (G) 2 and were housed individually in polycarbonate plastic cages with pine-wood shavings for bedding. Water in glass bottles and food were provided continuously and animals were maintained on a 12-h light, 12-h dark cycle (0600 -1800 h lights on). Briefly, animals were randomly assigned to one of four treatment groups: control, hypothyroid (HTx), PCB, or HTxϩPCB. Starting on G3, animals were weighed in the morning and provided with a single untreated wafer (mini-vanilla wafer, Keebler Co., Battle Creek, MI) 2 h before lights off. This initial period (G3-G6) trains animals to consume the wafer quickly and in its entirety during experimental treatment. Beginning on G7, wafers were dosed with A1254 (lot 124 -191; Accustandard Inc., New Haven, CT) dissolved in methanol and calibrated to deliver 5 mg/kg⅐d body weight. Animals in control and HTx groups received wafers dosed with methanol alone. All wafers were dosed in the morning and allowed to dry in a fume hood through the day. Dams in the HTx and HTxϩPCB groups were treated with a combination of potassium perchlorate (Sigma, St. Louis, MO) and methimazole (MMI; Sigma) in their drinking water as described previously (26) . This treatment was initiated incrementally as follows: from G7 to G9, 0.1% MMI plus 0.5% perchlorate; from G9 to G11, 0.1% MMI plus 0.1% perchlorate; and from G11 to postnatal day (P) 15, 0.02% MMI plus 0.5% perchlorate.
Male pups were weighed and killed on P15. Trunk blood was collected for serum hormone analysis, which have been reported previously (26) . Brains were removed from the skull, frozen on pulverized dry ice, and stored at Ϫ80 C until sectioned for in situ hybridization.
RIA
Total T 4 was measured in 5 l of rat serum as previously described (24) . Briefly, each assay tube contained 100 l barbital buffer [0.11 m sodium barbital, 0.1% (wt/vol) 8 anilino-1-napthalen-sulfonic acid sodium salt, 15% (wt/vol) bovine ␥-globulin, Cohn fraction II, 0.1% (wt/ vol) gelatin (pH 8.6)], 100 l anti-T 4 (rabbit; Sigma) diluted to a final concentration of 1:30,000, and 100 l 125 I-labeled T 4 (12,000 -15,000 cpm; PerkinElmer/NEN Life Science Products, Waltham, MA). Standards were prepared from T 4 (Sigma) measured using a Cahn electrobalance; standards were run in triplicate, whereas samples were run in duplicate. Standards were calibrated to measure serum T 4 levels from 0.4 to 25.6 g/dl. Tubes were incubated at 37 C for 30 min and then chilled on wet ice for 30 min. Bound counts were precipitated by adding 300 l ice-cold polyethylene glycol 8000 [20% (wt/vol); Sigma]. Tubes were centrifuged at 1800 ϫ g for 20 min at 4 C, the supernatant aspirated, and the pellet counted in a ␥-counter (Cobra II; PerkinElmer). The assay was run at 40 -50% binding; nonspecific binding was generally less than 8%.
Free T 4 was measured in 50 l of serum using a RIA kit (MP Biomedicals, Solon, OH) according to the manufacturer's instructions. We previously determined that parent PCBs did not interfere in the RIA for T 4 (our unpublished data).
Quantitative real-time PCR
Total RNA was extracted from frozen pituitary using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The resultant RNA pellet was resuspended in nuclease free water and quantified using UV spectrophotometry. Gel electrophoresis confirmed RNA integrity. Relative levels of TSH␤ were determined by quantitative real-time PCR using the QuantiTect SYBR Green RT-PCR kit (QIAGEN, Valencia, CA) and the Mx3000P real-time PCR machine (Stratagene, La Jolla, CA). Each 10-l reaction contained 1ϫ QuantiTect SYBR Green RT-PCR master mix, 0.5 m forward primer (TSH␤, 5Ј-AAT GCT GTC GTT CTC TTT TCC-3Ј, or ␤-actin, 5Ј-TGA ACC CTA AGG CCA ACC GTG AAA-3Ј), 0.5 m reverse primer (TSH␤, 5Ј-AGA ATG TCT GTG GCT TGG TGC-3Ј, or ␤-actin, 5Ј-ATA CAG GGA CAA CAC AGC CTG GAT-3Ј), 0.1 l reverse transcriptase and 200 ng total RNA. The conditions for cDNA synthesis and target amplification were as follows: one cycle of 50 C for 30 min; one cycle of 95 C for 15 min; and 40 cycles each of 95 C for 15 sec, 60 C for 30 sec, and 72 C for 30 sec. All samples were run in duplicate. Amplification values were normalized to ␤-actin mRNA, which was run in parallel duplicate wells. Although TH has been reported to increase ␤-actin expression in the cortex (43), we have not found previously that ␤-actin expression is affected by TH (44).
Moreover, cycle threshold values were not affected by TH or PCB treatment in the current experiment. Thus, we used ␤-actin expression as a fiducial for our TSH␤ mRNA measures.
In situ hybridization
We used in situ hybridization to measure the effects of treatments on RC3 and PCP-2 gene expression because this semiquantitative approach has a very high degree of neuroanatomical resolution. Specifically, RC3 expression in the hippocampus is responsive to TH only in the dentate gyrus, not in Ammon's horn (37) ; therefore, more quantitative approaches to measure RC3 mRNA (e.g. real-time PCR) would be revealing only if coupled to a method of RNA isolation that has a high degree of neuroanatomical resolution (e.g. laser capture microdissection). Coronal and sagittal sections of frozen brain tissues were taken at 12 m in a cryostat (Reichert-Jung Frigocut 2800N; Leica Corp., Deerfield, IL). Two adjacent sections were thaw mounted onto each microscope slide twice coated with gelatin and stored at Ϫ80 C until hybridization. The rostrocaudal placement of the section was matched using internal landmarks when slides were chosen for the in situ hybridization.
RC3/neurogranin in the rostral hippocampus was measured using a 3Ј-end-labeled 45-base oligonucleotide (IDT, Coralville, IA) directed against bp 830 -786 of the RC3/neurogranin mRNA (5Ј-ACC TGT CCA CGC GCC CAG CAT GCA GCT CTG CCT CCG CAG CCT CGG-3Ј). End labeling was carried out using terminal transferase (Roche Applied Sciences, Indianapolis, IN) and 33 P-dATP according to the manufacturer's instructions. PCP-2 mRNA was measured using a 33 P-cRNA probe that was in vitro transcribed from a cDNA kindly provided by Dr. Grant Anderson (University of Minnesota, Minneapolis, MN). Two slides from each brain, four sections total, were thawed at room temperature and hybridized as previously described (24, 45) . Sections from the same brain region were matched across treatment groups using specific internal landmarks. In the case of the hippocampus, we matched sections using the shape and size of the dentate gyrus and the lateral ventricles. In the case of the cerebellum, we collected midsagittal sections. Although it is difficult to be assured that the section in one brain exactly matched that of another, the brains were sectioned in random order and potential variation in the placement of the section would not represent a systematic error. After in situ hybridization, slides were exposed to BioMax film (Eastman Kodak, Rochester, NY) in x-ray cassettes along with 14 C-labeled standards (American Radiolabeled Chemicals Inc., St. Louis, MO) to control for overexposure. The hybridization signal was analyzed using an imaging system described previously (23, 46) . Film density was measured in the upper and lower leaflets of the dentate gyrus of P15 brains for RC3/neurogranin as previously described (25) except that we used a SPOT Insight 2 camera and a Macintosh G5 computer. Film density was measured over the dentate gyrus by an operator who did not know the identity of the image. Film density values of the dentate gyrus were averaged over the four sections for each brain, with one brain representing each litter. PCP-2 mRNA hybridized slides were dipped in NTB photographic emulsion (Eastman Kodak), allowed to air dry, and stored at 4 C for 72 h. Slides were then developed with Dektol developer, rinsed in water, and fixed. After rinsing in cold water, slides were counterstained with 0.5% methyl green and coverslipped using Permount. Silver grain reflectance was measured over the perikarya and dendrites of labeled Purkinje cells using dark-field optics.
Histological analysis
Sagittal sections of frozen P15 cerebellum were taken at 12 m in a cryostat (Reichert-Jung Frigocut 2800N; Leica). Two adjacent sections were thaw mounted onto microscope slides twice coated with gelatin and stored at Ϫ80 C.
Two slides per animal were thawed, fixed with 4% formaldehyde, and stained with hematoxylin and eosin (Sigma), dehydrated in ethanol, and coverslipped using Permount. Images were magnified using a Dage-72 series video camera equipped with a Nikon macrolens mounted on a bellows and captured using a Scion AG-5 capture board interfaced with NIH Image version 1.61 (W. Rashband, National Institute of Mental Health, Bethesda, MD) run on Macintosh G4. For each cerebellum, the deepest sulcus was located and a 1-mm grid was placed over the image. The area of each layer was measured over a 1-mm length using NIH image calibrated with a stage micrometer (Fig. 1) . Four sections were measured from each brain, with a single measurement made for each layer taken in a single section.
Statistical analysis
Results were analyzed using a two-way ANOVA. Post hoc tests, where appropriate, were performed by Fisher's protected least significant differences test (SuperAnova software; Abacus Concepts Inc., Berkeley, CA). Total T 4 and free T 4 RIA data were analyzed using a two-tailed unpaired t test. Statistical outliers were identified using the Grubb's test (GraphPad Prism, San Diego, CA; http://www.graphpad.com/quickcalcs). Sample loss during processing accounts for differences in sample size between groups. Only one male pup was used from each litter; thus, the statistical n represents the number of independent litters used in these studies.
Results
Serum hormone levels
Serum hormone levels are shown in Table 1 . Serum total T 4 levels for these animals have been published in a separate manuscript (26) and are provided here for completeness. Briefly, total T 4 levels were significantly lower in pups derived from all treatment groups, compared with control animals; total T 4 levels were not detectable in pups derived from dams treated with MMIϩperchlorate but were reduced to about 23% of control values in pups derived from dams exposed to A1254 alone. Likewise, serum-free T 4 levels were significantly lower in pups derived from all treatment groups, compared with control animals; free T 4 levels were not detectable in pups derived from dams treated with MMIϩperchlorate but were reduced to about 38% of control values in pups derived from dams exposed to A1254 alone. Values for control and PCB-treated animals were evaluated using unpaired two-tailed t test, which showed that free T 4 was significantly reduced in the PCB-treated animals (t ϭ 5.835, P ϭ 0.0001).
TSH␤ expression in the pituitary
Real-time PCR analysis of TSH␤ expression in the pituitary showed a significant effect of HTx (F 1,16 ϭ 15.662; P ϭ 0.0011; Fig. 2 ) by two-way ANOVA. In contrast, TSH␤ expression was not affected by PCB treatment (F 1,16 ϭ 0599; P Ͼ 0.05), and there was no significant interaction between these two treatments (F 1,16 ϭ 0.106; P Ͼ 0.05). Due to unequal variance across groups, normalized values were log transformed before statistical analysis was performed. For the purpose of presentation, untransformed values are shown in Fig. 2 . Post hoc analysis of these data demonstrated that TSH␤ mRNA levels were significant higher in the pituitaries of Htx animals and those Htx animals treated with PCBs, compared with controls. Interestingly, despite PCB treatment causing a significant reduction in serum total and free T 4 , pituitary TSH␤ mRNA levels were not affected by PCB treatment. However, it is important to note that because these animals were exposed to treatments during development, the TSH␤ mRNA levels we observed may reflect changes in cellular levels of TSH␤ mRNA, may reflect changes in the numbers of thyrotropes, or both. The use of a thyrotrope-specific fiducial in the real-time PCR would obviate caution in this interpretation, but none was available. Figure 3A shows the expression pattern of RC3/neurogranin in sections containing the upper (DG-upper) and lower (DG-lower) leaflets of the dentate gyrus; brain regions in which this gene is known to be affected by TH (37) . We obtained relative levels of RC3 mRNA using in situ hybridization because RC3 expression is regulated by TH only in very specific brain regions (e.g. Ref. 39); therefore, even microdissection would include brain tissue in which RC3 expression is not affected by thyroid status. The two-way ANOVA of RC3 expression in the dentate gyrus in P15 pups revealed a significant effect of HTx (F 1,22 ϭ 780; P ϭ 0.0001) and PCB (F 1,22 ϭ 6.786; P ϭ 0.0162) treatment in the lower leaflet; however, no significant interaction was observed (F 1,22 ϭ 1.047; P Ͼ 0.05). Similarly in the upper leaflet, we observe a significant effect of HTx (F 1,22 ϭ 568; P ϭ 0.001) and A, Film autoradiograms after in situ hybridization, representing the mean density in the dentate gyrus for each treatment group as graphically displayed in B. B, Graphic representation of film analysis as described in the text. The density of the film over the dentate gyrus was measured on digitized images using NIH Image J. Pups exposed to HTx and HTxϩPCB treatment exhibited significantly lower RC3/ neurogranin mRNA in both the upper and lower leaflet of the dentate gyrus. In contrast, RC3/neurogranin mRNA levels in pups exposed to PCB was significantly higher than that observed in control animals in both the upper and lower leaflet. Bars represent the mean Ϯ SEM. *, P Ͻ 0.01; ***, P Ͻ 0.0001, compared with control (control, n ϭ 7; HTx, n ϭ 5; PCB, n ϭ 7; HTxϩPCB, n ϭ 7). There was no significant effect of PCB treatment and no significant interaction. Bars represent the mean TSH␤/␤-actin Ϯ SEM. *, P Ͻ 0.01, compared with control (control, n ϭ 8; HTx, n ϭ 4; PCB, n ϭ 4; HTxϩPCB, n ϭ 3).
RC3 expression in the dentate gyrus
PCB (F 1,22 ϭ 7.955; P ϭ 0.01) treatment but no significant interaction between the two main effects. Post hoc analysis using Fisher's protected least significant differences test revealed that RC3 mRNA levels in HTx-and HTxϩPCB-treated animals were significantly lower than RC3 mRNA in controls and that RC3 expression in animals treated with PCB was significantly higher than in controls (Fig. 3B) .
PCP-2 expression in the cerebellum
PCP-2 expression was measured separately in the Purkinje cell perikarya and dendritic field (Fig. 4A) . Two-way ANOVA on PCP-2 expression in Purkinje perikarya revealed that there was no significant effect of HTx (F 1,21 ϭ 0.467; P Ͼ 0.05) or PCB exposure (F 1,21 ϭ 1.364; P Ͼ 0.05) but that there was a significant interaction (F 1,21 ϭ 4.523; P ϭ 0.0455). In the dendritic field, there was again a significant interaction of the two main effects (F 1,21 ϭ 8.202; P ϭ 0.0093) but no effect of HTx (F 1,21 ϭ 0.014; P Ͼ 0.05) or PCB treatment (F 1,21 ϭ 2.026; P Ͼ 0.05). In the Purkinje cell body, post hoc analysis revealed a significant increase in PCP-2 signal density in the HTxϩPCB group, compared with HTx alone. Likewise, in the dendritic field, signal density in the HTxϩPCB group was significantly increased, compared with both PCB and HTx alone (Fig. 4B) .
Cerebellar histogenesis
TH insufficiency is known to delay granule cell migration from the EGL to the internal granule layer (IGL). Therefore, we measured thickness of these layers in hematoxylin and eosin stained sagittal sections of cerebellum as an additional measure of TH action in the developing cerebellum in this experiment. Two-way ANOVA showed significant treatment effects of HTx (F 1,23 ϭ 79.782; P ϭ 0.0001), PCB (F 1,23 ϭ 6.106; P ϭ 0.0213), and the interaction of HTx and PCB (F 1,23 ϭ 7.085, P ϭ 0.0139) (Fig. 5) . Post hoc analysis showed that both HTx and HTxϩPCB-treated pups had a thicker EGL, compared with controls. There was no difference in EGL thickness between control and PCB-treated pups. However, HTx animals that were also treated with PCBs exhibited an EGL that was significantly thinner than that of HTx animals not treated with PCBs.
There was a significant effect of HTx (F 1,23 ϭ 54.224; P ϭ 0.0001) on thickness of the mitral layer (ML) but no effect of PCB (F 1,23 ϭ 0.006; P Ͼ 0.05) or an interaction between the two main effects (F 1,23 ϭ 3.583; P Ͼ 0.05). Post hoc analysis showed that the thickness of the ML was significantly reduced in HTx-treated animals, compared with control. There were no treatment effects on the thickness of the IGL; HTx (F 1,23 ϭ 0.072; P Ͼ 0.05), PCB (F 1,23 ϭ 0.744; P Ͼ 0.05); or the interaction of HTx and PCB (F 1,23 ϭ 1.078; P Ͼ 0.05) (Fig. 5 ).
Discussion
Our current findings demonstrate that developmental exposure to A1254, which produces a significant decrease in serum total and free T 4 , does not produce effects on end points of TH action in the developing brain that are produced when TH levels are brought to similar values with other goitrogens. Our PCB treatment resulted in an approximately 75% reduction in serum total T 4 and a 60% reduction in serum-free T 4 (Table 1 ). This degree of T 4 deficit, produced by treatment with propylthiouracil (PTU), is sufficient to cause an increase in serum TSH (47) , which changes in parallel to pituitary TSH␤ (48) . Moreover, as little as a 28% decrease in serum total T 4 produced by PTU is associated with significant changes in the cellular makeup of the corpus callosum (49) . Finally, treatment with PTU at 3 ppm, producing a 75% reduction in serum total T 4 , also produces the development of a large neuronal heterotopia in the corpus callosum (50) . Thus, it is enigmatic that PCBs can reduce serum total and free T 4 without affecting serum TSH (51) or TSH␤ mRNA in the pituitary gland or other downstream markers of TH action in the developing brain.
This finding is difficult to reconcile with an idealized model of the hypothalamic-pituitary-thyroid axis in which low free T 4 regulates serum TSH by negative feedback (e.g. Ref. 52) . One possible explanation is that there are specific PCB congeners in A1254 that exerts a TH agonistic effect that can ameliorate the effects of low TH. As we reported previously (25) , PCB exposure increased RC3 expression in the dentate gyrus. However, PCB exposure did not affect RC3 expression in hypothyroid animals. This observation is not likely to be an artifact of the experimental measurements. We confirmed that low serum total and free T 4 , produced by treatment with MMI is associated with significantly reduced RC3 mRNA expression in the dentate gyrus. The degree of this decrement in RC3 was much greater than the increase in RC3 expression observed in response to PCB exposure; thus, we expected to observe at least a small increase in RC3 expression in response to PCB treatment in hypothyroid animals if PCBs act as a direct TR agonist in vivo. The present FIG. 4 . Treatment effects on PCP-2 expression in the cerebellum of P15 rats. A, Dark-field image of PCP-2 expression in the cerebellum using radioactive in situ hybridization. B, The signal density was measured using dark-field optics. In the Purkinje cell perikarya, signal density was increased in the HTxϩPCB group, compared with HTx-only treatment. In the dendritic field, the signal density was significantly increased in the HTxϩPCB group, compared with both PCB and HTxonly treatment. Bars represent the mean Ϯ SEM. *, P Ͻ 0.05; **, P Ͻ 0.001 (control, n ϭ 7; HTx, n ϭ 4; PCB, n ϭ 7; HTxϩPCB, n ϭ 7).
observations remain perplexing because we previously observed that PCB effects on RC3 expression were likely to be transcriptional both because PCB exposure increased RC3 mRNA levels only in those brain areas in which RC3 expression is increased by thyroid hormone (37) and because single-cell levels of RC3 mRNA were increased by PCB exposure.
Likewise, we expected to observe that PCB exposure would produce a TH-like effect on PCP2 expression in Purkinje cells. We observed that PCP2 mRNA is localized in the Purkinje cell body and dendritic field, as had been previously reported (53) , but the effect of hypothyroidism on PCP2 mRNA expression was not robust. Several authors have shown that PCP-2 expression is suppressed in hypothyroid pups on P15 (e.g. Ref. 54) and that there are functional thyroid response elements in the PCP-2 gene (38), indicating a direct action of TH on PCP2 expression. Others have failed to observe changes in PCP-2 expression in the cerebellum of hypothyroid animals (e.g. Ref. 55 ). We observed a strong trend for PCP-2 mRNA reduction in hypothyroid animals as reported by Dong et al. (55) , but PCB exposure failed to increase its expression as it had done for RC3 in the hippocampus. PCB exposure did increase the expression of PCP-2 in hypothyroid animals; thus, PCB exposure exerted an action similar to that of TH, but only in hypothyroid animals.
Finally, we tested the effect of hypothyroidism and/or PCB exposure on a developmental event, namely cerebellar histogenesis. We confirmed that the external granule layer of the cerebellum is retained on P15 in hypothyroid animals, which further confirmed that our experimental treatments were effective. However, PCB exposure alone had no effect on cerebellar histogenesis but diminished the thickness of the EGL in hypothyroid animals. Thus, PCB exposure exerted a TH-like effect on cerebellar histogenesis but only in hypothyroid animals. This profile of effects of PCBs is similar to that observed on PCP2 expression but dissimilar from that observed with RC3 expression in the hippocampus.
These studies are the first to evaluate the interaction of thyroid status in combination with PCB exposure on molecular targets of TH action in the developing rat brain. The results indicate clearly that the effect of PCB exposure on TH signaling in the developing brain differs among specific end points of TH signaling. We considered the possibility that differences may reflect differences in TR isoform mediating TH action on different end points. Effects of TH on TSH␤ (56) and PCP-2 (39) mRNAs are mediated by the TR␤ receptor, whereas TH action on RC3 (39) expression and granule cell migration (42) are mediated by the TR␣ receptor. However, the different effects of PCB exposure on these various endpoints do not appear to be associated with the TR isoform. For example, PCB exposure increased RC3 expression (TR␣) only in euthyroid animals but affected cerebellar histogenesis only in animals made hypothyroid with MMI (TR␣). FIG. 5 . Treatment effects on the thickness of cerebellar layers in P15 rat pups. A, Hypothyroidism was associated with a significant increase in the thickness of the EGL, compared with control. Interestingly, the thickness of the EGL in HTx animals also treated with PCBs was significantly less than that of animals receiving HTx alone. In contrast, the thickness of the ML was reduced in HTx animals, whether or not they also received PCBs. No difference was observed in the thickness of the IGL. Bars represent the mean Ϯ SEM. *, P Ͻ 0.01; ***, P Ͻ 0.0001. B, Hematoxylin and eosin-stained sagittal sections of P15 rat cerebella. Scale bar, 100 m (control, n ϭ 9; HTx, n ϭ 4; PCB, n ϭ 7; HTxϩPCB, n ϭ 7).
Differences in PCB effects on these end points may also be related to the cellular context; for example, specific TR isoforms may interact with different cellular proteins that in some way influence PCB action on the TR. Moreover, TH may itself regulate some of this machinery, which could influence the specific pattern of PCB action on these end points. It is clear that some PCB congeners can bind to TRs and regulate gene expression. We showed previously that 4-OH-2Ј,3,3Ј,4Ј,5Ј-pentachlorobiphenyl can bind to the rat TR and can increase GH mRNA in GH3 cells as well as activate luciferase driven by a canonical thyroid response element (29) . Likewise, others have similarly shown the ability of hydroxylated PCBs to interact directly with the TR (35) .
It is also important to consider the potential role of PCB metabolism in its action on TH signaling. Parent PCB congeners do not appear to bind to TRs (24); rather, hydroxylated PCBs appear to be more capable of interacting with TRs. We recently reported that the metabolism of specific PCB congeners is required for their ability to drive TR action in rat pituitary cells in vitro (36) . Because this metabolism was dependent on induction of the cytochrome P450 enzyme Cyp1A1 by the aryl hydrocarbon receptor, it required a combination of PCB congeners that included those that activate the aryl hydrocarbon receptor and those that would be metabolized by Cyp1A1 to form TH agonists. Thus, it is possible that the ability of different cells or brain regions to metabolize PCBs may differ, depending on the degree to which Cyp1A1 is induced. In addition, it is possible that TH itself may influence Cyp1A1 induction such that euthyroid animals differ in their sensitivity to the agonist action of PCBs, compared with hypothyroid animals. These observations are germane in the present study because the PCB mixture used (A1254) has the same PCB congeners at the same concentration that we previously used to demonstrate the role of metabolism in PCB action on TH signaling (36) .
In conclusion, the current data demonstrate that PCB exposure produces different effects on a variety of end points of TH action in the developing brain. Although there are differences in the specific profile of effects, in no case do these end points behave in a manner predicted by total and free T 4 levels in PCB-treated animals. That is, the endocrine profile of low total and free T 4 induced by PCB exposure is not associated with any of the downstream consequences that occur when total and free T 4 are brought to the same level by PTU. This enigma has considerable implications for interpreting hormone levels in a clinical, regulatory, or epidemiological setting.
